ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 163 filers reported holding ZAI LAB LTD in Q2 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $94,282 | -76.7% | 3,400 | -72.1% | 0.00% | -100.0% |
| Q1 2023 | $404,774 | +50.3% | 12,170 | +38.8% | 0.00% | 0.0% |
| Q4 2022 | $269,239 | -10.3% | 8,770 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $300,000 | +22.0% | 8,770 | +23.7% | 0.00% | 0.0% |
| Q2 2022 | $246,000 | -21.2% | 7,090 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $312,000 | -8.5% | 7,090 | +30.8% | 0.00% | 0.0% |
| Q4 2021 | $341,000 | -40.3% | 5,420 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $571,000 | -40.5% | 5,420 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $959,000 | +48.0% | 5,420 | +11.5% | 0.01% | +50.0% |
| Q1 2021 | $648,000 | -1.5% | 4,860 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $658,000 | +135.0% | 4,860 | +44.2% | 0.00% | +100.0% |
| Q3 2020 | $280,000 | +1.1% | 3,370 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $277,000 | – | 3,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
| Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
| Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
| INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
| HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
| EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
| Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
| Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
| Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |